Ratings by Barclays (Glen Santangelo)
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 10/15/2026 | Teva Pharma | TEVA | Maintain | Overweight (N/A) |
|
Details | ||
| 10/12/2026 | Phreesia Inc. | PHR | Maintain | Equalweight (N/A) |
|
Details | ||
| 10/9/2026 | Medline Inc | MDLN | Maintain | Overweight (N/A) |
|
Details | ||
| 9/25/2026 | Ligand Pharma | LGND | New Coverage | Overweight (N/A) |
298.41 (307.82) |
3.15% | Details | |
| 9/18/2026 | HealthEquity, Inc | HQY | Maintain | Overweight (N/A) |
|
Details | ||
| 9/17/2026 | Amneal Pharmaceuticals | AMRX | Maintain | Overweight (N/A) |
|
Details | ||
| 9/16/2026 | Tarsus Pharmaceuticals | TARS | New Coverage | Overweight (N/A) |
79.95 (72.08) |
-9.84% | Details | |
| 9/16/2026 | Alvotech SA | ALVO | Upgrade | Overweight (Underweight) |
5.05 (4.79) |
-5.15% | Details | |
| 9/10/2026 | Lifestance Health Group | LFST | Maintain | Overweight (N/A) |
|
Details | ||
| 8/21/2026 | GoodRx Holdings Inc. | GDRX | Maintain | Underweight (N/A) |
|
Details | ||
| 8/21/2026 | Doximity Inc | DOCS | Maintain | Equalweight (N/A) |
|
Details | ||
| 8/21/2026 | Claritev | CTEV | Maintain | Overweight (N/A) |
|
Details | ||
| 8/20/2026 | Hims and Hers | HIMS | Maintain | Overweight (N/A) |
|
Details | ||
| 8/19/2026 | McKesson | MCK | Maintain | Overweight (N/A) |
|
Details | ||
| 8/19/2026 | Collegium Pharmaceutical | COLL | Maintain | Overweight (N/A) |
|
Details | ||
| 8/19/2026 | Amphastar Pharmaceuticals | AMPH | Maintain | Equalweight (N/A) |
|
Details | ||
| 8/17/2026 | Phathom Pharmaceuticals | PHAT | Maintain | Overweight (N/A) |
|
Details | ||
| 8/13/2026 | Cardinal Health | CAH | Maintain | Overweight (N/A) |
|
Details | ||
| 8/12/2026 | Teva Pharma | TEVA | Maintain | Overweight (N/A) |
|
Details | ||
| 8/11/2026 | IDEXX Laboratories | IDXX | Maintain | Overweight (N/A) |
|
Details | ||
| 8/6/2026 | Henry Schein | HSIC | Maintain | Overweight (N/A) |
|
Details | ||
| 8/5/2026 | Indivior | INDV | Maintain | Overweight (N/A) |
|
Details | ||
| 7/14/2026 | Lifestance Health Group | LFST | Maintain | Overweight (N/A) |
|
Details | ||
| 7/1/2026 | Zoetis Inc. | ZTS | Maintain | Equalweight (N/A) |
|
Details | ||
| 6/18/2026 | Indivior | INDV | New Coverage | Overweight (N/A) |
38.01 (35.33) |
-7.05% | Details | |
| 6/17/2026 | Hims and Hers | HIMS | Maintain | Overweight (N/A) |
|
Details | ||
| 6/11/2026 | Envista Holdings Corp. | NVST | Maintain | Overweight (N/A) |
|
Details | ||
| 6/10/2026 | McKesson | MCK | Maintain | Overweight (N/A) |
|
Details | ||
| 6/10/2026 | Cencora Inc | COR | Maintain | Overweight (N/A) |
|
Details | ||
| 6/3/2026 | Amphastar Pharmaceuticals | AMPH | Maintain | Equalweight (N/A) |
|
Details | ||
| 6/1/2026 | Medline Inc | MDLN | Maintain | Overweight (N/A) |
|
Details | ||
| 5/29/2026 | Medline Inc | MDLN | Maintain | Overweight (N/A) |
|
Details | ||
| 5/20/2026 | Amneal Pharmaceuticals | AMRX | Maintain | Overweight (N/A) |
|
Details | ||
| 5/19/2026 | Viatris | VTRS | Maintain | Overweight (N/A) |
|
Details | ||
| 5/18/2026 | Progyny | PGNY | Maintain | Overweight (N/A) |
|
Details | ||
| 5/14/2026 | Phreesia Inc. | PHR | Downgrade | Equalweight (Overweight) |
9.19 (12.72) |
38.41% | Details | |
| 5/14/2026 | Doximity Inc | DOCS | Downgrade | Equalweight (Overweight) |
23.39 (33.68) |
43.99% | Details | |
| 5/6/2026 | Teva Pharma | TEVA | Maintain | Overweight (N/A) |
|
Details | ||
| 4/24/2026 | Claritev | CTEV | New Coverage | Overweight (N/A) |
21.91 (23.50) |
7.26% | Details | |
| 4/8/2026 | Amphastar Pharmaceuticals | AMPH | Maintain | Equalweight (N/A) |
|
Details | ||
| 3/27/2026 | Phathom Pharmaceuticals | PHAT | Upgrade | Overweight (Equalweight) |
10.47 (7.01) |
-33.05% | Details | |
| 3/26/2026 | Teladoc | TDOC | Maintain | Equalweight (N/A) |
|
Details | ||
| 3/23/2026 | Alvotech SA | ALVO | Maintain | Underweight (N/A) |
|
Details | ||
| 3/23/2026 | Viatris | VTRS | Maintain | Overweight (N/A) |
|
Details | ||
| 3/19/2026 | Progyny | PGNY | Maintain | Overweight (N/A) |
|
Details | ||
| 3/19/2026 | Collegium Pharmaceutical | COLL | Maintain | Overweight (N/A) |
|
Details | ||
| 3/19/2026 | Teva Pharma | TEVA | Maintain | Overweight (N/A) |
|
Details | ||
| 3/18/2026 | ANI Pharmaceuticals | ANIP | Maintain | Overweight (N/A) |
|
Details | ||
| 3/17/2026 | Align Technology | ALGN | Upgrade | Overweight (Equalweight) |
164.23 (155.51) |
-5.31% | Details | |
| 3/11/2026 | Hims and Hers | HIMS | Maintain | Overweight (Overweight) |
|
Details | ||
| 3/9/2026 | TalkSpace | TALK | Maintain | Equalweight (N/A) |
|
Details | ||
| 3/6/2026 | Lifestance Health Group | LFST | Maintain | Overweight (N/A) |
|
Details | ||
| 2/26/2026 | Align Technology | ALGN | Maintain | Equalweight (N/A) |
|
Details | ||
| 2/25/2026 | Hims and Hers | HIMS | Maintain | Overweight (N/A) |
|
Details | ||
| 2/25/2026 | Bausch Health Companies | BHC | Maintain | Equalweight (Equalweight) |
|
Details | ||
| 2/24/2026 | Organon & Co. | OGN | Maintain | Underweight (N/A) |
|
Details | ||
| 2/24/2026 | Cardinal Health | CAH | Maintain | Overweight (N/A) |
|
Details | ||
| 2/23/2026 | TalkSpace | TALK | Maintain | Equalweight (Equalweight) |
|
Details | ||
| 2/18/2026 | McKesson | MCK | Maintain | Overweight (N/A) |
|
Details | ||
| 2/18/2026 | HealthEquity, Inc | HQY | Maintain | Overweight (N/A) |
|
Details | ||
| 2/13/2026 | Cencora Inc | COR | Maintain | Overweight (N/A) |
|
Details | ||
| 2/11/2026 | Envista Holdings Corp. | NVST | Maintain | Overweight (N/A) |
|
Details | ||
| 2/11/2026 | Doximity Inc | DOCS | Maintain | Overweight (N/A) |
|
Details | ||
| 2/5/2026 | IDEXX Laboratories | IDXX | Maintain | Overweight (N/A) |
|
Details | ||
| 1/30/2026 | Teva Pharma | TEVA | Maintain | Overweight (N/A) |
|
Details | ||
| 1/12/2026 | Medline Inc | MDLN | New Coverage | Overweight (N/A) |
41.25 (34.88) |
-15.44% | Details | |
| 1/9/2026 | Collegium Pharmaceutical | COLL | Maintain | Overweight (Overweight) |
|
Details | ||
| 12/16/2025 | Phreesia Inc. | PHR | Maintain | Overweight (N/A) |
|
Details | ||
| 12/9/2025 | Organon & Co. | OGN | New Coverage | Underweight (N/A) |
7.14 (13.75) |
92.58% | Details | |
| 12/9/2025 | Collegium Pharmaceutical | COLL | New Coverage | Overweight (N/A) |
47.91 (23.50) |
-50.95% | Details | |
| 12/9/2025 | Amphastar Pharmaceuticals | AMPH | New Coverage | Equalweight (N/A) |
26.77 (26.04) |
-2.73% | Details | |
| 12/9/2025 | Phathom Pharmaceuticals | PHAT | New Coverage | Equalweight (N/A) |
14.58 (7.01) |
-51.92% | Details | |
| 12/9/2025 | Amneal Pharmaceuticals | AMRX | New Coverage | Overweight (N/A) |
12.18 (20.48) |
68.14% | Details | |
| 12/9/2025 | Teva Pharma | TEVA | New Coverage | Overweight (N/A) |
28.46 (40.21) |
41.29% | Details | |
| 12/9/2025 | Tarsus Pharmaceuticals | TARS | New Coverage | Overweight (N/A) |
81.77 (72.08) |
-11.85% | Details | |
| 12/9/2025 | Alvotech SA | ALVO | New Coverage | Underweight (N/A) |
5.47 (5.05) |
-7.68% | Details | |
| 12/9/2025 | Viatris | VTRS | New Coverage | Overweight (N/A) |
10.93 (18.48) |
69.08% | Details | |
| 12/9/2025 | Pacira Pharmaceuticals | PCRX | New Coverage | Equalweight (N/A) |
23.99 (36.34) |
51.48% | Details | |
| 12/9/2025 | Elanco Animal Health | ELAN | New Coverage | Overweight (N/A) |
21.90 (22.69) |
3.61% | Details | |
| 12/9/2025 | Bausch Health Companies | BHC | New Coverage | Equalweight (N/A) |
6.93 (6.49) |
-6.35% | Details | |
| 12/9/2025 | Teladoc | TDOC | New Coverage | Equalweight (N/A) |
7.59 (6.32) |
-16.73% | Details | |
| 12/9/2025 | Progyny | PGNY | New Coverage | Overweight (N/A) |
24.02 (31.19) |
29.85% | Details | |
| 12/9/2025 | Phreesia Inc. | PHR | New Coverage | Overweight (N/A) |
20.29 (12.72) |
-37.31% | Details | |
| 12/9/2025 | TalkSpace | TALk | New Coverage | Equalweight (N/A) |
3.08 (5.25) |
70.45% | Details | |
| 12/9/2025 | Henry Schein | HSIC | New Coverage | Overweight (N/A) |
73.62 (86.00) |
16.82% | Details | |
| 12/9/2025 | Zoetis Inc. | ZTS | New Coverage | Equalweight (N/A) |
118.65 (82.00) |
-30.89% | Details | |
| 12/9/2025 | Envista Holdings Corp. | NVST | New Coverage | Overweight (N/A) |
20.23 (23.97) |
18.49% | Details | |
| 12/9/2025 | IDEXX Laboratories | IDXX | New Coverage | Overweight (N/A) |
714.10 (566.76) |
-20.63% | Details | |
| 12/9/2025 | Cencora Inc | COR | New Coverage | Overweight (N/A) |
339.66 (338.48) |
-0.35% | Details | |
| 12/9/2025 | Cardinal Health | CAH | New Coverage | Overweight (N/A) |
198.83 (255.64) |
28.57% | Details | |
| 12/9/2025 | Lifestance Health Group | LFST | New Coverage | Overweight (N/A) |
6.48 (12.56) |
93.83% | Details | |
| 12/9/2025 | GoodRx Holdings Inc. | GDRX | New Coverage | Underweight (N/A) |
2.71 (3.62) |
33.58% | Details | |
| 12/9/2025 | McKesson | MCK | New Coverage | Overweight (N/A) |
808.62 (1012.34) |
25.19% | Details | |
| 12/9/2025 | HealthEquity, Inc | HQY | New Coverage | Overweight (N/A) |
94.51 (100.97) |
6.84% | Details | |
| 12/9/2025 | Doximity Inc | DOCS | New Coverage | Overweight (N/A) |
45.93 (33.68) |
-26.67% | Details | |
| 12/9/2025 | Align Technology | ALGN | New Coverage | Equalweight (N/A) |
157.21 (164.23) |
4.47% | Details |
